Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Relapsed/Refractory Hodgkin's Lymphoma
NCT00478959Phase 2Completed
- Sponsor
- University Health Network
- Start
- Dec 2006
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lenalidomide in Hodgkin lymphoma (HL), sponsored by University Health Network. Started Dec 2006; status: completed.
02
Drugs
lenalidomide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00478959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478959.